cholest-4-en-3-one has been researched along with chenodeoxycholic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salen, G; Shefer, S; Tint, GS | 1 |
| Johnston, IM; Nolan, JD; Pruzanski, ME; Shapiro, DA; Vassie, C; Walters, JR | 1 |
1 trial(s) available for cholest-4-en-3-one and chenodeoxycholic acid
| Article | Year |
|---|---|
The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.
Topics: Adult; Aged; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestenones; Diarrhea; Female; Fibroblast Growth Factors; Humans; Ileum; Male; Middle Aged; Receptors, Cytoplasmic and Nuclear | 2015 |
1 other study(ies) available for cholest-4-en-3-one and chenodeoxycholic acid
| Article | Year |
|---|---|
Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
Topics: Adult; Bile Acids and Salts; Brain Diseases; Carbon Radioisotopes; Chenodeoxycholic Acid; Cholestanols; Cholestenes; Cholestenones; Cholesterol; Cholic Acid; Cholic Acids; Humans; In Vitro Techniques; Male; Microsomes, Liver; Middle Aged; Tendons; Xanthomatosis | 1984 |